Syner-G BioPharma Group, founded in 2007, is a strategic development and delivery partner for biopharma innovators. The firm specialises in turning scientific breakthroughs into therapies through comprehensive Chemistry, Manufacturing, and Controls (CMC) solutions, covering pharmaceutical development, regulatory affairs, and quality/cGxP compliance. Its proprietary CMC 360™ platform integrates these disciplines into a single approach.
The company employs over 400 experts and has been involved in more than 500 successful regulatory filings. Its operations span North America and India, with a headquarters in Framingham, Massachusetts. Syner-G BioPharma has been recognised as a BioSpace Best Places to Work winner for multiple consecutive years.
